MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.
Understanding the underlying molecular mechanisms of defined cancers is crucial for effective personalized therapies. Translocations of the mixed-lineage leukemia (MLL) gene produce fusion proteins such as MLL-AF4 that disrupt epigenetic pathways and cause poor-prognosis leukemias. Here, we find tha...
Κύριοι συγγραφείς: | Kerry, J, Godfrey, L, Repapi, E, Tapia, M, Blackledge, N, Ma, H, Ballabio, E, O'Byrne, S, Ponthan, F, Heidenreich, O, Roy, A, Roberts, I, Konopleva, M, Klose, R, Geng, H, Milne, T |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Cell Press
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
ανά: Jon Kerry, κ.ά.
Έκδοση: (2017-01-01) -
MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
ανά: Godfrey, L, κ.ά.
Έκδοση: (2016) -
The role of DOT1L in MLL-AF4 leukaemia
ανά: Godfrey, L
Έκδοση: (2018) -
Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.
ανά: Ballabio, E, κ.ά.
Έκδοση: (2012) -
P314: THERAPEUTICALLY TARGETING THE UNIQUE BARCODE OF MLL/AF4
ανά: R. Cameron, κ.ά.
Έκδοση: (2022-06-01)